DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs. 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).
J Clin Oncol 2019;
37: 3501
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl 15_suppl Available from: 3501. [Last accessed on 2020 Apr 05]
Access:
We do not assume any responsibility for the contents of the web pages of other providers.